Switching from intravitreal ranibizumab to bevacizumab for age-related macular degeneration.
about
Switching from intravitreal ranibizumab to bevacizumab for age-related macular degeneration.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 December 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Switching from intravitreal ra ...... -related macular degeneration.
@en
Switching from intravitreal ra ...... -related macular degeneration.
@nl
type
label
Switching from intravitreal ra ...... -related macular degeneration.
@en
Switching from intravitreal ra ...... -related macular degeneration.
@nl
prefLabel
Switching from intravitreal ra ...... -related macular degeneration.
@en
Switching from intravitreal ra ...... -related macular degeneration.
@nl
P2093
P2860
P356
P1433
P1476
Switching from intravitreal ra ...... -related macular degeneration.
@en
P2093
Hirofumi Kono
Kenichi Kimoto
Kisaburo Yamada
Toshiaki Kubota
P2860
P304
P356
10.5402/2011/916789
P577
2011-12-21T00:00:00Z